Introduction • Chronic Inflammatory Denyelinating Polyneuropathy (CIDP) is a chronic, acquired, immune-mediated condition affecting the peripheral nervous system • CIDP is rare autoimmune disorder characterized by progressive peripheral neuropathy • Guidelines for the diagnosis and treatment of CIDP have been developed, the large variety of clinical and electrophysiological variants, associated systemuc conditions, and lack of sustained improvement with standard treatments in up to one third of cases provide challenges to the clinician in practice • It is treatable in the majority of the cases • Numerous clinical trials have establish the short-term efficacy of immune therapies such as corticosteroids, plasma exchange (PE), and introvebous immune globulin (IVIg) CIDP vs GBS • CIDP is distinguish from acute inflammatory CIDP GBS demyelinating Time course Polyphasic Monophasic polyradiculopathy (remission (AIDP), the most and relap) common form of Antibody Unclear Identified Guillain-Barre Syndrome (GBS), by time course Severity of clinical Less Severe and steroid symptom responsiveness Response to Yes No • CIDP typically responds steroid to corticosteroid therapy, whereas AIDP does not Clinical features of CIPD (Joint Task Force of The EFNS And PNS, 2010)
Progressive symmetrical or asymmetrical polyradiculopathy
Relapsing or progressive course >2 months
Proximal weakness usually prominent
Large fiber sensory loss in the distal limbs (vibration and joint position sense)
Generalized hypo-reflex or areflex
Clinical & Electrodiagnostic Criteria Inclusion Criteria Exclusion Criteria Typical CIDP Atypical CIDP - Chronic progressive, -Predominantly - Infection, drug/ toxin stepwise, or distal - Hereditary recurrent symmetric - Asymmetric - Sphincter distrubance prox & distal - Focal - Diagnosis of MMN weakness & sensory - Pure motor - IgM monoclonal gammanopathy dysfunction all - Pure Sensory - Other demyelinating neruopathy extremities - ±2 months durations - Cranial nerve affected - Tendon reflexes absent/ reduced in all extremities Thank You